Prior to the 1970s, researchers widely believed cervical cancer was caused by the herpes simplex virus. That understanding ...

Italian pharma Alfasigma has penned a 125 million euro ($145 million) deal for the rights to an injectable form of an investigational herpes simplex virus (HSV) encephalitis treatment. | Italian ...

Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

Alfasigma S.p.A. ("Alfasigma"), a global pharmaceutical company, and Innovative Molecules GmbH ("Innovative Molecules"), a ...

SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

Adibelivir is a next generation helicase-primase inhibitor. The oral formulation is advancing toward Phase 2 development for genital herpes, while the parenteral formulation is dedicated exclusively ...

Herpes is common – and manageable. Here's how it can affect pregnancy, birth, and your baby, plus what you can do to protect ...

A first-time mom received backlash for saying she does not let her mom kiss her newborn. Doctors and pediatric infectious ...

Manisha Sharma a contestant on MasterChef India Season 9 has become the latest internet sensation for her resilient journey ...

The genetic modification therapy market presents key opportunities in developing specialized treatments for rare, inherited, ...

Two women from Norfolk have had their lives transformed by sight restoring surgery after becoming the first patients to benefit from a pioneering “two for one” corneal transplant procedure.

Eric Donnenfeld’s corneal health case presentations and panel discussion at OSN New York are always popular with meeting ...